|
Market Closed -
TEL AVIV STOCK EXCHANGE
18:24:10 17/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 154.00 ILa | +0.59% |
|
-0.52% | -48.77% |
| 09-11 | L.I.A. Pure Capital Intends to Commence a Special Tender Offer to Evogene | CI |
| 09-04 | Evogene Ltd. Approves Board Appointments | CI |
Company Valuation: Evogene Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 71.23 | 26.16 | 42.08 | 13 | 8.219 | 8.029 | - | - |
| Change | - | -63.27% | 60.85% | -69.1% | -36.78% | -2.31% | - | - |
| Enterprise Value (EV) | 71.23 | 26.16 | 42.08 | 13 | 8.219 | 8.029 | 8.029 | 8.029 |
| Change | - | -63.27% | 60.85% | -69.1% | -36.78% | -2.31% | 0% | 0% |
| P/E | - | - | - | - | - | - | - | - |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 76.6x | 15.6x | 7.46x | 1.53x | 2.13x | 5.41x | 3.09x | 1.62x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 5.41x | 3.09x | 1.62x |
| EV / EBITDA | - | - | -0x | -0x | -0x | -0.75x | -0.79x | -0.83x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -0.66x | -0.66x | -0.68x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | - | - | - | - | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.93 | 1.675 | 5.64 | 8.511 | 3.853 | 1.484 | 2.6 | 4.95 |
| EBITDA 1 | - | - | -22.04 | -17.39 | -12.89 | -10.72 | -10.2 | -9.628 |
| EBIT 1 | -30.95 | -26.94 | -26.51 | -22.21 | -14.03 | -12.18 | -12.1 | -11.73 |
| Net income 1 | -27.79 | -26.64 | -23.88 | -16.48 | -8.485 | -16.69 | -13.92 | -13.49 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 53.750 | 22.350 | 29.980 | 7.269 | 3.006 | 1.540 | 1.540 | 1.540 |
| Nbr of stocks (in thousands) | 4,116 | 4,122 | 5,055 | 6,515 | 8,716 | 15,801 | - | - |
| Announcement Date | 10/03/22 | 09/03/23 | 07/03/24 | 06/03/25 | 05/03/26 | - | - | - |
1USD in Million2
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 7.99M | |
| 31.46x | 5.67x | 16.98x | 1.03% | 45.91B | |
| 34.62x | 3.34x | 14.39x | -.--% | 44.25B | |
| -20.04x | 230.9x | -21.44x | -.--% | 41.99B | |
| 45.6x | 5.26x | 28.79x | -.--% | 39.58B | |
| 26.88x | 8.11x | 20.55x | 0.42% | 31.08B | |
| 35.05x | 5.75x | 26.13x | -.--% | 17.21B | |
| 24.9x | 2.15x | 9.33x | 1.07% | 14.96B | |
| 29.53x | 1.94x | 11.89x | -.--% | 13.42B | |
| Average | 26.00x | 32.89x | 13.33x | 0.32% | 27.6B | |
| Weighted average by Cap. | 24.75x | 43.16x | 12.25x | 0.31% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EVGN Stock
- Valuation Evogene Ltd.
Select your edition
All financial news and data tailored to specific country editions
